EcoDrugPlus

Ribosomal Protein S9

Ensembl ID : ENSTTRG00000006572
Gene Symbol: RPS9
1 Cross references
219 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P0

Ensembl ID : ENSTTRG00000005658
Gene Symbol: RPLP0
1 Cross references
173 Possible Orthologues:

Secretin Receptor

Ensembl ID : ENSTTRG00000007324
Gene Symbol: SCTR
1 Cross references
130 Possible Orthologues:

Selectin E

Ensembl ID : ENSTTRG00000004071
Gene Symbol: SELE
1 Cross references
197 Possible Orthologues:

Selectin L

Ensembl ID : ENSTTRG00000004067
Gene Symbol: SELL
1 Cross references
86 Possible Orthologues:

Selectin P

Ensembl ID : ENSTTRG00000004061
Gene Symbol: SELP
1 Cross references
120 Possible Orthologues:

Serpin Family C Member 1

Ensembl ID : ENSTTRG00000008568
Gene Symbol: SERPINC1
1 Cross references
199 Possible Orthologues:

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSTTRG00000005674
Gene Symbol: SIGMAR1
1 Cross references
204 Possible Orthologues:

Sirtuin 1

Ensembl ID : ENSTTRG00000016262
Gene Symbol: SIRT1
1 Cross references
157 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSTTRG00000008437
Gene Symbol: SMO
1 Cross references
204 Possible Orthologues:

Sodium Channel Epithelial 1 Subunit Alpha

Ensembl ID : ENSTTRG00000014465
Gene Symbol: SCNN1A
1 Cross references
153 Possible Orthologues:

Sodium Channel Epithelial 1 Subunit Beta

Ensembl ID : ENSTTRG00000005185
Gene Symbol: SCNN1B
1 Cross references
151 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).